First Report of Tar Spot on Orange Geiger, Cordia sebestena, Caused by Diatractium cordianum in Florida.

In July 2007, tar spot symptoms observed on citrus leaves Geiger, sebestena Cordia L. (boraginaceae), in the landscape and commercial nursery in Homestead, FL. This disease appears to be spreading and locally severe. Symptoms are circular, little spots hypertrophy of about 5 to 8 cm in diameter, slightly chlorotic on abaxial surface and has a lot of stromal blackened circular, 0.2-0.4 mm, on the lower surface of leaves. Old and yellowing leaves, the area around the fixed point of pale green.

Embedded in the stroma much Perithecia, 173-312 m diameter, circular to irregular in shape, with a neck that as many as 200 pM lateral length and 73-104 m in diameter. ASCI, 77-92 × 11 to 13 um, are elongated, two-celled ascospores, 50-61 × 3 to 5 um which have narrowing of the striking wall dividing cells. Dimensions and appearance of pathogens fits tightly with those published for Diatractium cordianum (Ellis & Kelsey) Syd (1). Young, asymptomatic C. sebestena leaves were sprayed to runoff with ascospores suspension of approximately 104 ml-1 were harvested from the affected leaves. inoculated leaves were placed on a paper towel saturated with water in petri dishes and kept in a growth chamber at 25 ° C with fluorescent light at 10 h day-1.

Symptoms similar to those observed in the affected trees in the landscape began to evolve after 21 days and Perithecia clear after 28 days. An ITS 1, 2 ITS and 5.8S rDNA sequences deposited in GenBank (Accession No. EU541488). A herbarium specimens deposited in the US National Fungus Collections (BPI No. 878 441). It is a new host record for D. cordianum and is the first time the pathogens have been reported in the United States. previous record comes from Venezuela and several Caribbean islands, including Cuba and Jamaica.

Symptoms of this disease has not been observed in Texas wild olive, Cordia boissieri, near exposed C. sebestena. P. F. Cannon (1) suggests that the disease has no economic impact. However, the striking nature of the C sebestena symptoms and the importance of this tree in South Florida ornamental trade (2) shows that this disease can be significant in the last host. References: (1) P. F. Cannon. Mycol. Res. 92: 327, 1989. (2) D. E. F. G. Gilman and Watson

 First Report of Tar Spot on Orange Geiger, Cordia sebestena, Caused by Diatractium cordianum in Florida.
First Report of Tar Spot on Orange Geiger, Cordia sebestena, Caused by Diatractium cordianum in Florida.

Randomized, controlled clinical pilot study of venous leg ulcers treated with two types of shockwave therapy.

Background. Venous leg ulcers difficult to heal wounds. The basis of their physiotherapeutic treatment is compression therapy. However, over the years, looking for additional or other methods to supplement the treatment of venous ulcers, which would shorten the duration of treatment, are ongoing. One such method is shockwave therapy.

Method. The aim of our study was to compare radial shockwave therapy (R-ESWT) with a focused shockwave therapy (F-ESWT) in the treatment of venous leg ulcers. Patients were randomly assigned to a group of trees. In the first group of radial shockwave therapy (0.17mJ / mm2, 100 impulses / cm2, 5 Hz), the second group focused shockwave therapy (0.173mJ / mm2, 100 impulses / cm2, 5 Hz) is used and in the third group used a standard treatment. Patients in the shockwave therapy group were given 6 treatments at intervals of five days.

Total area, circumference, Gilman index, maximum length and maximum width of the ulcer was measured. The third group of patients with wet gauze dressing with salt and gently compressing the elastic bandage used (SWC standard wound care).

BID

CSB-CL002698HU1 10 μg plasmid + 200μl Glycerol Ask for price

BID

CSB-CL002698HU2 10 μg plasmid + 200μl Glycerol Ask for price

BID

pro-627 2µg
EUR 60
Description: Recombinant Human BH3 Interacting Domain Death Agonist

Bid

MBS8534494-01mL 0.1mL
EUR 345

Bid

MBS8534494-01mLAF405L 0.1mL(AF405L)
EUR 565

Bid

MBS8534494-01mLAF405S 0.1mL(AF405S)
EUR 565

Bid

MBS8534494-01mLAF610 0.1mL(AF610)
EUR 565

Bid

MBS8534494-01mLAF635 0.1mL(AF635)
EUR 565

Bid BH3

5-00760 4 x 1mg Ask for price

Bid BH3

MBS8246224-10mg 10mg
EUR 715

Bid BH3

MBS8246224-1mg 1mg
EUR 260

Bid BH3

MBS8246224-5mg 5mg
EUR 510

Bid BH3

MBS8246224-5x10mg 5x10mg
EUR 3140

BID siRNA

20-abx909104
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

BID siRNA

20-abx909105
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

BID siRNA

20-abx900636
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

Bid Peptide

3353P 0.05 mg
EUR 197.7
Description: (CT) Bid peptide

Bid Peptide

3355P 0.05 mg
EUR 197.7
Description: (IN) Bid peptide

BID protein

30R-1173 100 ug
EUR 622
Description: Purified recombinant Human BID protein

BID Peptide

45-021P 0.1 mg
EUR 405.6
Description: (CT) BID Peptide

Bid Peptide

MBS151779-005mg 0.05mg
EUR 175

Bid Peptide

MBS151779-5x005mg 5x0.05mg
EUR 770

Bid Peptide

MBS152911-005mg 0.05mg
EUR 175

Bid Peptide

MBS152911-5x005mg 5x0.05mg
EUR 770

Bid antibody

10R-8490 100 ul
EUR 471.6
Description: Mouse monoclonal Bid antibody

Bid antibody

10R-8491 100 ul
EUR 471.6
Description: Mouse monoclonal Bid antibody

BID antibody

10R-10974 100 ug
EUR 344
Description: Mouse monoclonal BID antibody

BID antibody

10R-1121 100 ul
EUR 320
Description: Mouse monoclonal BID antibody

Bid antibody

20R-2964 100 ul
EUR 471.6
Description: Rabbit polyclonal Bid antibody

Bid antibody

20R-1486 100 ug
EUR 807.6
Description: Rabbit polyclonal Bid antibody

Bid Antibody

24251 100ul
EUR 479

Bid Antibody

24251-100ul 100ul
EUR 468

Bid Antibody

24252 100ul
EUR 479

Bid Antibody

24252-100ul 100ul
EUR 468

Bid Antibody

3272-100 each
EUR 379.2

Bid Antibody

3272-30T each
EUR 175.2

BID Antibody

32014 100ul
EUR 439

BID Antibody

32014-100ul 100ul
EUR 302.4

BID Antibody

31037 100ul
EUR 319

BID Antibody

31037-100ul 100ul
EUR 302.4

BID Antibody

31037-50ul 50ul
EUR 224.4

Bid Antibody

3172-100 each
EUR 379.2

Bid Antibody

3172-30T each
EUR 175.2

Bid Antibody

3353-002mg 0.02 mg
EUR 206.18
Description: Bid Antibody: Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. The Bcl-2 family of proteins is comprised of critical regulators of apoptosis that can be divided into two classes: those that inhibit apoptosis and those that promote cell death. Bid, a pro-apoptotic Bcl-2 family member, is cleaved by caspase-8 in response to apoptotic signals, exposing the Bcl-2 homology 3 (BH3) domain which is normally buried in the full-length protein. The cleaved complex is myris-toylated and translocated to the mitochondrial membrane where it may induce mitochondrial Bax and Bak to oligomerize.

Bid Antibody

3353-01mg 0.1 mg
EUR 523.7
Description: Bid Antibody: Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. The Bcl-2 family of proteins is comprised of critical regulators of apoptosis that can be divided into two classes: those that inhibit apoptosis and those that promote cell death. Bid, a pro-apoptotic Bcl-2 family member, is cleaved by caspase-8 in response to apoptotic signals, exposing the Bcl-2 homology 3 (BH3) domain which is normally buried in the full-length protein. The cleaved complex is myris-toylated and translocated to the mitochondrial membrane where it may induce mitochondrial Bax and Bak to oligomerize.

Bid Antibody

3355-002mg 0.02 mg
EUR 206.18
Description: Bid Antibody: Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. The Bcl-2 family of proteins is comprised of critical regulators of apoptosis that can be divided into two classes: those that inhibit apoptosis and those that promote cell death. Bid, a pro-apoptotic Bcl-2 family member, is cleaved by caspase-8 in response to apoptotic signals, exposing the Bcl-2 homology 3 (BH3) domain which is normally buried in the full-length protein. The cleaved complex is myris-toylated and translocated to the mitochondrial membrane where it may induce mitochondrial Bax and Bak to oligomerize.

Bid Antibody

3355-01mg 0.1 mg
EUR 523.7
Description: Bid Antibody: Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. The Bcl-2 family of proteins is comprised of critical regulators of apoptosis that can be divided into two classes: those that inhibit apoptosis and those that promote cell death. Bid, a pro-apoptotic Bcl-2 family member, is cleaved by caspase-8 in response to apoptotic signals, exposing the Bcl-2 homology 3 (BH3) domain which is normally buried in the full-length protein. The cleaved complex is myris-toylated and translocated to the mitochondrial membrane where it may induce mitochondrial Bax and Bak to oligomerize.

Bid Antibody

49505 100ul
EUR 499

Bid Antibody

49505-100ul 100ul
EUR 399.6

Bid Antibody

49505-50ul 50ul
EUR 286.8

BID Antibody

1-CSB-PA787438
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against BID. Recognizes BID from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:5000, WB:1:200-1:2000, IHC:1:25-1:100

BID Antibody

E031037 100μg/100μl
EUR 255
Description: Available in various conjugation types.

BID Antibody

E10-30198 100μg/100μl
EUR 225
Description: Available in various conjugation types.

BID Antibody

E19-6016 100μg/100μl
EUR 225
Description: Available in various conjugation types.

BID Antibody

DF6016 200ul
EUR 420

BID Antibody

DF6016-100ul 100ul
EUR 280

BID Antibody

DF6016-200ul 200ul
EUR 350

Bid Antibody

E90017 100ul
EUR 225
Description: Available in various conjugation types.

BID Antibody

E90210 100ul
EUR 255
Description: Available in various conjugation types.

BID Antibody

E38PA4351 100ul
EUR 225
Description: Available in various conjugation types.

BID antibody

E314605 200ul
EUR 275
Description: Available in various conjugation types.

Bid Antibody

E2220005 100ug
EUR 225
Description: Available in various conjugation types.

BID Antibody

BF0373-100ul 100ul
EUR 350

BID Antibody

BF0373-200ul 200ul
EUR 450

BID Antibody

BF0373-50ul 50ul
EUR 250

BID Antibody

CAC11767-100ug 100ug
EUR 314

BID Antibody

CAC11767-50ug 50ug
EUR 199.2

BID antibody

CAF50046-100ug 100ug
EUR 312

BID antibody

70R-15995 50 ul
EUR 289
Description: Rabbit polyclonal BID antibody

Bid antibody

70R-11670 100 ug
EUR 343
Description: Rabbit polyclonal Bid antibody

Bid antibody

70R-11734 100 ug
EUR 343
Description: Rabbit polyclonal Bid antibody

BID antibody

70R-31114 100 ug
EUR 294
Description: Rabbit polyclonal BID antibody

BID antibody

70R-31344 100 ug
EUR 294
Description: Rabbit polyclonal BID antibody

BID Antibody

AF6879 100ul
EUR 420

BID Antibody

AF6879-100ul 100ul
EUR 280

BID Antibody

AF6879-200ul 200ul
EUR 350

BID Antibody

1-CSB-PA002698GA01HU
  • Ask for price
  • Ask for price
  • 150ul
  • 50ul
Description: A polyclonal antibody against BID. Recognizes BID from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

BID Antibody

1-CSB-PA002698HA01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against BID. Recognizes BID from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:1000-1:2000

BID Antibody

1-CSB-PA225375
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against BID. Recognizes BID from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:5000, WB:1:200-1:2000, IHC:1:25-1:100

BID Antibody

1-CSB-PA000994
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against BID. Recognizes BID from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/10000

BID Antibody

1-CSB-PA000015
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against BID. Recognizes BID from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000

BID Antibody

ABD6016 100ug
EUR 325

Bid Antibody

F42702-0.08ML 0.08 ml
EUR 140.25
Description: The major proteolytic product p15 BID allows the release of cytochrome c (By similarity). Isoform 1, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis. Isoform 3 does not induce apoptosis. Counters the protective effect of Bcl-2. [UniProt]

Bid Antibody

F42702-0.4ML 0.4 ml
EUR 322.15
Description: The major proteolytic product p15 BID allows the release of cytochrome c (By similarity). Isoform 1, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis. Isoform 3 does not induce apoptosis. Counters the protective effect of Bcl-2. [UniProt]

Bid Antibody

F42703-0.08ML 0.08 ml
EUR 140.25
Description: Bid is a death agonist that heterodimerizes with either agonist BAX or antagonist BCL2. Bid is a member of the BCL-2 family of cell death regulators. It is a mediator of mitochondrial damage induced by caspase-8 (CASP8); CASP8 cleaves this encoded protein, and the COOH-terminal part translocates to mitochondria where it triggers cytochrome c release.

Bid Antibody

F42703-0.4ML 0.4 ml
EUR 322.15
Description: Bid is a death agonist that heterodimerizes with either agonist BAX or antagonist BCL2. Bid is a member of the BCL-2 family of cell death regulators. It is a mediator of mitochondrial damage induced by caspase-8 (CASP8); CASP8 cleaves this encoded protein, and the COOH-terminal part translocates to mitochondria where it triggers cytochrome c release.

Bid Antibody

GWB-475F99 0.05 mg Ask for price

BID Antibody

GWB-MW143H 50ug Ask for price

Bid Antibody

GWB-B8D1C3 0.05 mg Ask for price

Bid Antibody

R31123 100 ug
EUR 356.15
Description: Bid (BH3-Interacting Domain Death Agonist), is a pro-apoptotic member of the Bcl-2 protein family. The BCL2 family of proteins consists of both antagonists and agonists that regulate apoptosis and compete through dimerization. By fluorescence in situ hybridization, Wang et al.(1998) mapped the human BID gene to 22q11. Luo et al.(1998) reported the purification of a cytosolic protein that induces cytochrome c release from mitochondria in response to caspase-8, the apical caspase activated by cell surface death receptors such as FAS and TNF.

Bid Antibody

R31459 100 ug
EUR 356.15
Description: Bid (BH3-Interacting Domain Death Agonist), is a pro-apoptotic member of the Bcl-2 protein family. The BCL2 family of proteins consists of both antagonists and agonists that regulate apoptosis and compete through dimerization. By fluorescence in situ hybridization, Wang et al. (1998) mapped the human BID gene to 22q11. Luo et al. (1998) reported the purification of a cytosolic protein that induces cytochrome c release from mitochondria in response to caspase-8, the apical caspase activated by cell surface death receptors such as FAS and TNF.

BID Antibody

R36322-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: BH3 interacting domain death agonist

Bid Antibody

R32856 100 ug
EUR 356.15
Description: BID (BH3-Interacting Domain Death Agonist), is a pro-apoptotic member of the Bcl-2 protein family. The BCL2 family of proteins consists of both antagonists and agonists that regulate apoptosis and compete through dimerization. By fluorescence in situ hybridization, the human BID gene is mapped to 22q11. It is reported the purification of a cytosolic protein that induces cytochrome c release from mitochondria in response to caspase-8, the apical caspase activated by cell surface death receptors such as FAS and TNF.

Bid Antibody

RQ5945 100 ug
EUR 356.15
Description: BID (BH3-Interacting Domain Death Agonist), is a pro-apoptotic member of the Bcl-2 protein family. The BCL2 family of proteins consists of both antagonists and agonists that regulate apoptosis and compete through dimerization. By fluorescence in situ hybridization, Wang et al. (1998) mapped the human BID gene to 22q11. Luo et al. (1998) reported the purification of a cytosolic protein that induces cytochrome c release from mitochondria in response to caspase-8, the apical caspase activated by cell surface death receptors such as FAS and TNF.

BID antibody

BF0373 100ug
EUR 355

BID Antibody

MBS7123403-005mL 0.05mL
EUR 190

BID Antibody

MBS7123403-01mL 0.1mL
EUR 270

BID Antibody

MBS7123403-5x01mL 5x0.1mL
EUR 1205

BID Antibody

MBS7123404-005mL 0.05mL
EUR 190

BID Antibody

MBS7123404-01mL 0.1mL
EUR 270

BID Antibody

MBS7123404-5x01mL 5x0.1mL
EUR 1205

BID Antibody

MBS7121564-005mg 0.05mg
EUR 150

BID Antibody

MBS7121564-01mg 0.1mg
EUR 190

BID Antibody

MBS7121564-5x01mg 5x0.1mg
EUR 845

BID Antibody

MBS7121817-005mg 0.05mg
EUR 150

BID Antibody

MBS7121817-01mg 0.1mg
EUR 190

BID Antibody

MBS7121817-5x01mg 5x0.1mg
EUR 845

Bid Antibody

MBS9402388-01mL 0.1mL
EUR 495

Bid Antibody

MBS9402388-5x01mL 5x0.1mL
EUR 2075

BID Antibody

MBS9402484-01mL 0.1mL
EUR 305

BID Antibody

MBS9402484-5x01mL 5x0.1mL
EUR 1230

BID Antibody

MBS9403310-005mL 0.05mL
EUR 300

BID Antibody

MBS9403310-01mL 0.1mL
EUR 390

BID Antibody

MBS9403310-5x01mL 5x0.1mL
EUR 1610

Bid Antibody

MBS9410166-01mL 0.1mL
EUR 495

Bid Antibody

MBS9410166-5x01mL 5x0.1mL
EUR 2075

BID Antibody

MBS8582456-01mL 0.1mL
EUR 305

BID Antibody

MBS8582456-01mLAF405L 0.1mL(AF405L)
EUR 465

BID Antibody

MBS8582456-01mLAF405S 0.1mL(AF405S)
EUR 465

BID Antibody

MBS8582456-01mLAF610 0.1mL(AF610)
EUR 465

BID Antibody

MBS8582456-01mLAF635 0.1mL(AF635)
EUR 465

BID Antibody

MBS9215414-005mL 0.05mL
EUR 210

BID Antibody

MBS9215414-02mL 0.2mL
EUR 430

BID Antibody

MBS9215414-5x02mL 5x0.2mL
EUR 1910

Bid Antibody

MBS857426-01mL 0.1mL
EUR 305

Bid Antibody

MBS857426-01mLAF405L 0.1mL(AF405L)
EUR 565

Bid Antibody

MBS857426-01mLAF405S 0.1mL(AF405S)
EUR 565

Bid Antibody

MBS857426-01mLAF610 0.1mL(AF610)
EUR 565

Bid Antibody

MBS857426-01mLAF635 0.1mL(AF635)
EUR 565

BID Antibody

MBS850664-01mg 0.1mg
EUR 305

BID Antibody

MBS850664-01mLAF405L 0.1mL(AF405L)
EUR 565

BID Antibody

MBS850664-01mLAF405S 0.1mL(AF405S)
EUR 565

BID Antibody

MBS850664-01mLAF610 0.1mL(AF610)
EUR 565

BID Antibody

MBS850664-01mLAF635 0.1mL(AF635)
EUR 565

BID Antibody

MBS8515933-01mg 0.1mg
EUR 305

BID Antibody

MBS8515933-01mLAF405L 0.1mL(AF405L)
EUR 465

BID Antibody

MBS8515933-01mLAF405S 0.1mL(AF405S)
EUR 465

BID Antibody

MBS8515933-01mLAF610 0.1mL(AF610)
EUR 465

BID Antibody

MBS8515933-01mLAF635 0.1mL(AF635)
EUR 465

BID Antibody

MBS8501408-01mL 0.1mL
EUR 325

BID Antibody

MBS8501408-01mLAF405L 0.1mL(AF405L)
EUR 565

BID Antibody

MBS8501408-01mLAF405S 0.1mL(AF405S)
EUR 565

BID Antibody

MBS8501408-01mLAF610 0.1mL(AF610)
EUR 565

Results. Analysis of the results showed that a complete cure ulcer was achieved in 35% of patients treated with radial shockwave, 26% of patients with focused shock waves used